ALERTEDGE TRADE BRIEF — HSIC (Henry Schein)

Generated at $80.50 | Breakout Level: $80.19

SETUP

HSIC is clearing a meaningful resistance level at $80.19 on above-average volume (1.22x), closing a 1.9% gap from the prior session close of $79.00. The stock is recovering from its 52-week low of $61.95 and building toward the upper range, with the 52-week high at $89.29 providing a clear runway. The breakout is clean and confirmed at the live price, suggesting genuine buying interest rather than a false spike.

CATALYSTS

Recent earnings have been broadly constructive — four of the last five quarters beat estimates, including a strong May 2025 beat of $1.15 vs $1.11. The headline catalyst is HSIC's own guidance of a $125M profit lift by 2026, signaling operational confidence. Insider buying has been consistent and notable, with Director Daniel William K purchasing 10,000 shares at roughly $69 in May — now sitting on a gain, which adds credibility to the bullish thesis. Dental demand described as steady supports the core business.

RISKS

The risk/reward at 1:1.67 is acceptable but not exceptional, leaving limited margin for error. The stop at $78.81 is relatively tight — a broader market pullback or any negative health care sector headlines could easily trigger it. One analyst note flags HSIC as a stock to approach with caution. The February 2025 earnings miss is a reminder execution can slip. Next earnings are not until August 2026, so there is no near-term catalyst to accelerate the move.

CONVICTION: Medium

Solid insider accumulation and consistent earnings beats support the breakout, but the modest volume confirmation and cautious analyst sentiment cap conviction at medium.